• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

上皮-间质转化介导的肿瘤治疗抵抗

Epithelial-Mesenchymal Transition-Mediated Tumor Therapeutic Resistance.

机构信息

Department of Oral and Maxillofacial Surgery, School and Hospital of Stomatology, Jilin University, Changchun 130021, China.

Department of Oral Emergency, Hospital of Stomatology, Jilin University, Changchun 130021, China.

出版信息

Molecules. 2022 Jul 25;27(15):4750. doi: 10.3390/molecules27154750.

DOI:10.3390/molecules27154750
PMID:35897925
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9331826/
Abstract

Cancer is one of the world's most burdensome diseases, with increasing prevalence and a high mortality rate threat. Tumor recurrence and metastasis due to treatment resistance are two of the primary reasons that cancers have been so difficult to treat. The epithelial-mesenchymal transition (EMT) is essential for tumor drug resistance. EMT causes tumor cells to produce mesenchymal stem cells and quickly adapt to various injuries, showing a treatment-resistant phenotype. In addition, multiple signaling pathways and regulatory mechanisms are involved in the EMT, resulting in resistance to treatment and hard eradication of the tumors. The purpose of this study is to review the link between EMT, therapeutic resistance, and the molecular process, and to offer a theoretical framework for EMT-based tumor-sensitization therapy.

摘要

癌症是世界上最具负担性的疾病之一,其发病率不断上升,死亡率高。由于治疗耐药性导致的肿瘤复发和转移是癌症难以治疗的两个主要原因。上皮-间充质转化(EMT)是肿瘤耐药性的关键。EMT 使肿瘤细胞产生间充质干细胞,并迅速适应各种损伤,表现出治疗耐药表型。此外,多种信号通路和调节机制参与 EMT,导致治疗耐药和肿瘤难以根除。本研究旨在综述 EMT、治疗耐药性和分子过程之间的联系,并为基于 EMT 的肿瘤增敏治疗提供理论框架。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9672/9331826/f1f9de52f170/molecules-27-04750-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9672/9331826/ef0d4ba28464/molecules-27-04750-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9672/9331826/a81ffe50bd16/molecules-27-04750-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9672/9331826/f1f9de52f170/molecules-27-04750-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9672/9331826/ef0d4ba28464/molecules-27-04750-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9672/9331826/a81ffe50bd16/molecules-27-04750-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/9672/9331826/f1f9de52f170/molecules-27-04750-g003.jpg

相似文献

1
Epithelial-Mesenchymal Transition-Mediated Tumor Therapeutic Resistance.上皮-间质转化介导的肿瘤治疗抵抗
Molecules. 2022 Jul 25;27(15):4750. doi: 10.3390/molecules27154750.
2
Role of JAK/STAT3 Signaling in the Regulation of Metastasis, the Transition of Cancer Stem Cells, and Chemoresistance of Cancer by Epithelial-Mesenchymal Transition.JAK/STAT3信号通路在上皮-间质转化调控肿瘤转移、癌症干细胞转变及肿瘤化疗耐药中的作用
Cells. 2020 Jan 15;9(1):217. doi: 10.3390/cells9010217.
3
Targeting Epithelial-Mesenchymal Transition (EMT) to Overcome Drug Resistance in Cancer.靶向上皮-间质转化(EMT)以克服癌症中的耐药性
Molecules. 2016 Jul 22;21(7):965. doi: 10.3390/molecules21070965.
4
The network of epithelial-mesenchymal transition: potential new targets for tumor resistance.上皮-间质转化网络:肿瘤耐药性的潜在新靶点
J Cancer Res Clin Oncol. 2015 Oct;141(10):1697-713. doi: 10.1007/s00432-014-1840-y. Epub 2014 Oct 1.
5
The correlation between cancer stem cells and epithelial-mesenchymal transition: molecular mechanisms and significance in cancer theragnosis.癌症干细胞与上皮-间充质转化的相关性:分子机制及其在癌症治疗中的意义。
Front Immunol. 2024 Sep 30;15:1417201. doi: 10.3389/fimmu.2024.1417201. eCollection 2024.
6
The epithelial to mesenchymal transition (EMT) and cancer stem cells: implication for treatment resistance in pancreatic cancer.上皮-间质转化(EMT)与癌症干细胞:对胰腺癌治疗耐药性的影响
Mol Cancer. 2017 Feb 28;16(1):52. doi: 10.1186/s12943-017-0624-9.
7
Epithelial Mesenchymal Transition in Aggressive Lung Cancers.侵袭性肺癌中的上皮-间质转化
Adv Exp Med Biol. 2016;890:37-56. doi: 10.1007/978-3-319-24932-2_3.
8
The epithelial-mesenchymal transition and cancer stem cells: functional and mechanistic links.上皮-间质转化与癌症干细胞:功能及机制联系
Curr Pharm Des. 2015;21(10):1279-91. doi: 10.2174/1381612821666141211115611.
9
The therapeutic potential of targeting the epithelial-mesenchymal transition in cancer.靶向肿瘤上皮-间质转化的治疗潜力。
Expert Opin Ther Targets. 2014 Jul;18(7):731-45. doi: 10.1517/14728222.2014.909807. Epub 2014 Apr 23.
10
Induction of metastasis, cancer stem cell phenotype, and oncogenic metabolism in cancer cells by ionizing radiation.电离辐射诱导癌细胞发生转移、癌症干细胞表型及致癌代谢。
Mol Cancer. 2017 Jan 30;16(1):10. doi: 10.1186/s12943-016-0577-4.

引用本文的文献

1
Epithelial-Mesenchymal Transition in Cancer: Insights Into Therapeutic Targets and Clinical Implications.癌症中的上皮-间质转化:对治疗靶点及临床意义的见解
MedComm (2020). 2025 Aug 29;6(9):e70333. doi: 10.1002/mco2.70333. eCollection 2025 Sep.
2
Growth Hormone Signaling in Bladder Cancer: Transcriptomic Profiling of Patient Samples and In Vitro Evidence of Therapy Resistance via ABC Transporters and EMT Activation.膀胱癌中的生长激素信号传导:患者样本的转录组分析及通过ABC转运蛋白和上皮-间质转化激活产生治疗抗性的体外证据
Int J Mol Sci. 2025 Jul 23;26(15):7113. doi: 10.3390/ijms26157113.
3
Mechanisms underlying prostate cancer sensitivity to reactive oxygen species: overcoming radiotherapy resistance and recent clinical advances.

本文引用的文献

1
Identification of EMT-Related Genes and Prognostic Signature With Significant Implications on Biological Properties and Oncology Treatment of Lower Grade Gliomas.鉴定与EMT相关的基因及预后特征,对低级别胶质瘤的生物学特性和肿瘤治疗具有重要意义。
Front Cell Dev Biol. 2022 May 17;10:887693. doi: 10.3389/fcell.2022.887693. eCollection 2022.
2
Novel Insights on Lipid Metabolism Alterations in Drug Resistance in Cancer.癌症耐药中脂质代谢改变的新见解
Front Cell Dev Biol. 2022 May 13;10:875318. doi: 10.3389/fcell.2022.875318. eCollection 2022.
3
The potential role of nicotine in breast cancer initiation, development, angiogenesis, invasion, metastasis, and resistance to therapy.
前列腺癌对活性氧敏感的潜在机制:克服放疗抗性及近期临床进展
Cancer Biol Med. 2025 Jul 10;22(7):747-61. doi: 10.20892/j.issn.2095-3941.2024.0584.
4
Revisiting Treatment Strategies: Addressing Epithelial-to-Mesenchymal Transition-Induced Resistance in Hepatocellular Carcinoma.重新审视治疗策略:应对肝细胞癌中上皮-间质转化诱导的耐药性
BME Front. 2025 Jun 24;6:0144. doi: 10.34133/bmef.0144. eCollection 2025.
5
Regulator of cullins-1 predicts a poor prognosis and regulates epithelial-mesenchymal transition process through GSK-3β/Wnt signaling in renal cell carcinoma.Cullin-1调节因子预示着肾细胞癌预后不良,并通过GSK-3β/ Wnt信号通路调控上皮-间质转化过程。
Transl Androl Urol. 2025 Apr 30;14(4):974-985. doi: 10.21037/tau-2024-646. Epub 2025 Apr 27.
6
Evaluation of the antiangiogenic effect of AMG232 in multiple myeloma coculture systems.AMG232在多发性骨髓瘤共培养系统中的抗血管生成作用评估。
Med Oncol. 2025 Mar 13;42(4):107. doi: 10.1007/s12032-025-02659-8.
7
The Landscape of PARP Inhibitors in Solid Cancers.实体癌中PARP抑制剂的研究概况
Onco Targets Ther. 2025 Mar 2;18:297-317. doi: 10.2147/OTT.S499226. eCollection 2025.
8
Exploring the Role of Epithelial-Mesenchymal Transcriptional Factors Involved in Hematological Malignancy and Solid Tumors: A Systematic Review.探索上皮-间质转录因子在血液系统恶性肿瘤和实体瘤中的作用:一项系统综述
Cancers (Basel). 2025 Feb 5;17(3):529. doi: 10.3390/cancers17030529.
9
AXL signaling in cancer: from molecular insights to targeted therapies.癌症中的AXL信号传导:从分子洞察到靶向治疗。
Signal Transduct Target Ther. 2025 Feb 10;10(1):37. doi: 10.1038/s41392-024-02121-7.
10
Reprogrammed lipid metabolism in advanced resistant cancers: an upcoming therapeutic opportunity.晚期耐药癌症中重编程的脂质代谢:一个即将到来的治疗机会。
Cancer Drug Resist. 2024 Nov 19;7:45. doi: 10.20517/cdr.2024.131. eCollection 2024.
尼古丁在乳腺癌发生、发展、血管生成、侵袭、转移和治疗耐药中的潜在作用。
Breast Cancer. 2022 Sep;29(5):778-789. doi: 10.1007/s12282-022-01369-7. Epub 2022 May 18.
4
Targeting breast cancer resistance protein (BCRP/ABCG2): Functional inhibitors and expression modulators.靶向乳腺癌耐药蛋白(BCRP/ABCG2):功能抑制剂和表达调节剂。
Eur J Med Chem. 2022 Jul 5;237:114346. doi: 10.1016/j.ejmech.2022.114346. Epub 2022 Apr 6.
5
Drug resistance and combating drug resistance in cancer.癌症中的耐药性与抗耐药性
Cancer Drug Resist. 2019;2(2):141-160. doi: 10.20517/cdr.2019.10. Epub 2019 Jun 19.
6
Evidence That Tumor Microenvironment Initiates Epithelial-To-Mesenchymal Transition and Calebin A can Suppress it in Colorectal Cancer Cells.肿瘤微环境引发上皮-间质转化及Calebin A可抑制结肠癌细胞中该转化的证据。
Front Pharmacol. 2021 Jul 2;12:699842. doi: 10.3389/fphar.2021.699842. eCollection 2021.
7
MicroRNA-210-3p is transcriptionally upregulated by hypoxia induction and thus promoting EMT and chemoresistance in glioma cells.miR-210-3p 可被低氧诱导转录上调,从而促进胶质瘤细胞 EMT 和化疗耐药。
PLoS One. 2021 Jul 1;16(7):e0253522. doi: 10.1371/journal.pone.0253522. eCollection 2021.
8
The role of non-coding RNAs in ABC transporters regulation and their clinical implications of multidrug resistance in cancer.非编码 RNA 在 ABC 转运蛋白调控中的作用及其在癌症多药耐药中的临床意义。
Expert Opin Drug Metab Toxicol. 2021 Mar;17(3):291-306. doi: 10.1080/17425255.2021.1887139. Epub 2021 Feb 22.
9
Tuft and Cancer Stem Cell Marker DCLK1: A New Target to Enhance Anti-Tumor Immunity in the Tumor Microenvironment.簇绒细胞和癌症干细胞标志物DCLK1:增强肿瘤微环境中抗肿瘤免疫的新靶点。
Cancers (Basel). 2020 Dec 17;12(12):3801. doi: 10.3390/cancers12123801.
10
VEGF-C mediates tumor growth and metastasis through promoting EMT-epithelial breast cancer cell crosstalk.VEGF-C 通过促进 EMT-上皮型乳腺癌细胞串扰来介导肿瘤生长和转移。
Oncogene. 2021 Feb;40(5):964-979. doi: 10.1038/s41388-020-01539-x. Epub 2020 Dec 9.